Across TCGA pan-cancer cohorts, RNU1-132P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU1-132P’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RNU1-132P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU1-132P is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.
LUSC and THCA are the cancer types where RNU1-132P tumor–normal differential expression is most reproducible.